Laurence Lytton Takes 1.3M Share Stake in NeuroOne Medical (NMTC)
Ticker: NMTC · Form: SC 13G · Filed: Jan 11, 2024 · CIK: 1500198
| Field | Detail |
|---|---|
| Company | Neuroone Medical Technologies CORP (NMTC) |
| Form Type | SC 13G |
| Filed Date | Jan 11, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-ownership, beneficial-ownership, institutional-filing
TL;DR
**Laurence Lytton just disclosed a big 1.3M share position in NMTC, signaling a notable individual bet.**
AI Summary
Laurence W. Lytton, an individual investor, has reported beneficial ownership of 1,304,102 shares of NeuroOne Medical Technologies Corp. (NMTC) common stock as of December 28, 2023. This represents a significant stake, giving him sole voting and dispositive power over these shares. This matters to investors because a large individual holding can signal confidence in the company's future, but also means a single person has substantial influence over voting matters.
Why It Matters
A substantial individual stake like this can influence corporate governance and potentially impact stock price through future buying or selling activity.
Risk Assessment
Risk Level: medium — While a large individual stake can be a vote of confidence, it also concentrates power, meaning a single person's decisions could significantly impact the company.
Analyst Insight
Investors should monitor future filings by Laurence W. Lytton for any changes in his ownership, as a significant increase or decrease could signal a shift in his confidence in NeuroOne Medical Technologies Corp. and potentially impact the stock price.
Key Numbers
- 1,304,102 — Shares Beneficially Owned (Represents the total number of shares Laurence W. Lytton has sole voting and dispositive power over in NeuroOne Medical Technologies Corp.)
- December 28, 2023 — Event Date (The specific date that triggered the requirement for this SC 13G filing.)
Key Players & Entities
- Laurence W. Lytton (person) — Reporting Person, beneficial owner of shares
- NeuroOne Medical Technologies Corp. (company) — Issuer of the securities
- 1,304,102 (dollar_amount) — Number of shares beneficially owned by Laurence W. Lytton
- December 28, 2023 (dollar_amount) — Date of event requiring the filing
- $0.001 (dollar_amount) — Par value of common stock
Forward-Looking Statements
- Laurence W. Lytton will maintain his significant stake in NeuroOne Medical Technologies Corp. for the foreseeable future. (Laurence W. Lytton) — medium confidence, target: Q3 2024
- The substantial individual ownership by Laurence W. Lytton could lead to increased scrutiny of corporate governance decisions at NeuroOne Medical Technologies Corp. (NeuroOne Medical Technologies Corp.) — medium confidence, target: Q2 2024
FAQ
Who is the reporting person in this SC 13G filing?
The reporting person is Laurence W. Lytton, as stated in Item 1 of the Schedule 13G.
What is the name of the issuer whose securities are being reported?
The issuer is NeuroOne Medical Technologies Corporation, as identified in the 'Name of Issuer' section of the filing.
How many shares of NeuroOne Medical Technologies Corp. does Laurence W. Lytton beneficially own with sole voting power?
Laurence W. Lytton beneficially owns 1,304,102 shares with sole voting power, as reported in Item 5 of the Schedule 13G.
What was the date of the event that required this Schedule 13G filing?
The date of the event which required the filing of this statement was December 28, 2023, as indicated on the cover page.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(c), as marked with an 'X' on the cover page.
Filing Stats: 911 words · 4 min read · ~3 pages · Grade level 6.9 · Accepted 2024-01-11 13:04:48
Key Financial Figures
- $0.001 — ame of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 64130
Filing Documents
- nmtc.htm (SC 13G) — 28KB
- 0000935836-24-000025.txt ( ) — 29KB
Ownership
Item 4. Ownership. See Items 5-9 and 11 of the cover page. The percentages reported in this Schedule 13G are based on 25,311,404 shares of Common Stock outstanding as of January 3, 2024, as reported in the Prospectus Supplement filed by the Issuer on January 5, 2024.
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
Ownership of More than Five Percent on Behalf of Another Person
Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group. Not applicable
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group Not applicable.
Certification
Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated:January 11, 2024 /s/ Laurence W. LyttonI Laurence W. Lytton